Describe Phyllodes Tumour in detail.

The Concept

A phyllodes tumour (cystosarcoma phyllodes) is a fibroepithelial tumour of the breast that, like a fibroadenoma, contains both stromal and epithelial elements — but with a much more cellular, overgrown stroma. The name 'phyllodes' (Greek for 'leaf-like') describes the leaf-like clefts seen on cut section and histology. Its significance is that, unlike the harmless fibroadenoma it resembles, it has a tendency to recur locally and a spectrum of malignant potential, so it is managed quite differently.

Clinical Features

It typically occurs in women older than those with fibroadenoma (around 40–50) and presents as a firm, mobile, often large and rapidly growing breast lump. The history of a smooth mobile lump that has grown quickly to a large size, sometimes stretching and shining the overlying skin, is characteristic and helps distinguish it clinically from a stable fibroadenoma.

Classification & Management

On histology, phyllodes tumours are graded benign, borderline or malignant according to stromal features (cellularity, mitoses, margins, overgrowth). Because even benign ones recur if incompletely removed, the treatment is wide local excision with a clear margin (about 1 cm) — not simple enucleation as for a fibroadenoma; large tumours may require mastectomy. The malignant variant spreads haematogenously (like a sarcoma, e.g. To the lung) rather than to lymph nodes, so axillary clearance is not routinely required.

Distinguishing It from Fibroadenoma

The clinically vital comparison is with the fibroadenoma it mimics. Points favouring a phyllodes tumour are an older patient, a larger size, and rapid recent growth of a previously stable or new lump. The distinction genuinely matters because the operations differ: a fibroadenoma can be simply enucleated or observed, whereas a phyllodes tumour requires wide excision with a clear margin to prevent local recurrence — so mislabelling a phyllodes tumour as a fibroadenoma and 'shelling it out' leads to recurrence.

Exam Pointer

For the viva, anchor the answer on the single defining idea and its safe rule: state the mechanism, the classic clinical picture, the mandatory role of triple assessment where a lump or discharge is involved, and the specific management — and be ready to contrast the condition with the malignancy it can mimic, since that contrast is what examiners most often probe.

Management & Follow-up

Because a phyllodes tumour recurs if incompletely excised, treatment is wide local excision with a clear margin of about 1 cm (mastectomy for very large tumours), and — unlike breast carcinoma — axillary clearance is not routine, since the malignant variant spreads haematogenously (to the lung) rather than to nodes. Patients are followed for local recurrence, which even benign phyllodes tumours can show. The recurring exam theme is the contrast with fibroadenoma: an older patient, a larger and rapidly growing lump, and an operation demanding a proper margin rather than simple enucleation.

Wide excision margins are required — it recurs locally.

• Phyllodes tumour = fibroepithelial tumour with a hypercellular, overgrown stroma; leaf-like clefts.
• Older than fibroadenoma patients (~40–50); firm, mobile, often large, rapidly growing lump.
• Graded benign / borderline / malignant; tends to recur locally.
• Treat by wide local excision with ~1 cm clear margin (not enucleation); mastectomy for large tumours.
• Malignant type spreads haematogenously (lung), not to nodes — no routine axillary clearance.